A clinical trial was undertaken using three different inhalant anaesthetic agents and one intravenous anaesthetic agent in dogs undergoing routine desexing surgery. Healthy adult dogs undergoing either ovariohysterectomy or castration were assessed as to their demeanour, with the more excitable dogs being placed in groups receiving premedication with acepromazine and morphine. All dogs were then randomly assigned an anaesthetic agent for induction of general anaesthesia. The agents were the inhalants halothane, isoflurane and sevoflurane, and the intravenous agent propofol. Inhalant inductions were undertaken using a tight fitting mask attached to a standard anaesthetic machine with a rebreathing circuit, with the maximum dose of inhalant available from a standard vaporiser. Propofol inductions were undertaken via intravenous catheter. Dogs induced with propofol were randomly assigned one of the three inhalant agents for maintenance. Those induced by inhalant agent were maintained using the same agent. The surgical procedure was undertaken in standard fashion, as was recovery from anaesthesia. All dogs received the non-steroidal anti-inflammatory agent meloxicam. Data collection was divided into three stages: induction, maintenance, and recovery from anaesthesia. Variables measured at induction of anaesthesia were time to intubation, number of intubation attempts, tolerance of mask, quality of induction and quality of transfer to the maintenance stage. Standard variables for monitoring of anaesthesia were recorded throughout the maintenance of anaesthesia. Variables measured at recovery were time to righting, time to standing and quality of recovery. The mean time to intubation when using the newer inhalant sevoflurane (196.2 � 14.8sec, mean � SE) was not significantly different to that for halothane (221.4 � 14.0sec) or isoflurane (172.4 � 15.0sec). Time to intubation with isoflurane was significantly faster than with halothane. Mean time to intubation with propofol (85.4 � 7.7sec) was significantly faster than that for any of the three inhalants. Choice of inhalant had no effect on quality of induction. The use of premedication significantly improved the quality of induction. The use of propofol for induction likewise significantly improved the quality of induction. Standard cardiorespiratory variables measured during the maintenance phase of anaesthesia remained within normal clinical ranges for all three inhalants, and were therefore not further analysed. Choice of inhalant agent had no significant effect on the time to righting or standing in recovery. The use of propofol for induction had no effect on these variables. Animals placed in groups receiving premedication had significantly longer times to righting and standing. The oesophageal temperature at the end of the procedure had a significant effect on times to righting and standing, with lower temperatures contributing to slower recoveries. Independent of procedure time, male dogs had shorter times to righting than female dogs.

A clinical trial was undertaken using three different inhalant anaesthetic agents and one intravenous anaesthetic agent in dogs undergoing routine desexing surgery. Healthy adult dogs undergoing either ovariohysterectomy or castration were assessed as to their demeanour, with the more excitable dogs being placed in groups receiving premedication with acepromazine and morphine. All dogs were then randomly assigned an anaesthetic agent for induction of general anaesthesia. The agents were the inhalants halothane, isoflurane and sevoflurane, and the intravenous agent propofol. Inhalant inductions were undertaken using a tight fitting mask attached to a standard anaesthetic machine with a rebreathing circuit, with the maximum dose of inhalant available from a standard vaporiser. Propofol inductions were undertaken via intravenous catheter. Dogs induced with propofol were randomly assigned one of the three inhalant agents for maintenance. Those induced by inhalant agent were maintained using the same agent. The surgical procedure was undertaken in standard fashion, as was recovery from anaesthesia. All dogs received the non-steroidal anti-inflammatory agent meloxicam. Data collection was divided into three stages: induction, maintenance, and recovery from anaesthesia. Variables measured at induction of anaesthesia were time to intubation, number of intubation attempts, tolerance of mask, quality of induction and quality of transfer to the maintenance stage. Standard variables for monitoring of anaesthesia were recorded throughout the maintenance of anaesthesia. Variables measured at recovery were time to righting, time to standing and quality of recovery. The mean time to intubation when using the newer inhalant sevoflurane (196.2 � 14.8sec, mean � SE) was not significantly different to that for halothane (221.4 � 14.0sec) or isoflurane (172.4 � 15.0sec). Time to intubation with isoflurane was significantly faster than with halothane. Mean time to intubation with propofol (85.4 � 7.7sec) was significantly faster than that for any of the three inhalants. Choice of inhalant had no effect on quality of induction. The use of premedication significantly improved the quality of induction. The use of propofol for induction likewise significantly improved the quality of induction. Standard cardiorespiratory variables measured during the maintenance phase of anaesthesia remained within normal clinical ranges for all three inhalants, and were therefore not further analysed. Choice of inhalant agent had no significant effect on the time to righting or standing in recovery. The use of propofol for induction had no effect on these variables. Animals placed in groups receiving premedication had significantly longer times to righting and standing. The oesophageal temperature at the end of the procedure had a significant effect on times to righting and standing, with lower temperatures contributing to slower recoveries. Independent of procedure time, male dogs had shorter times to righting than female dogs.

Les polymères à mémoire de forme (SMP) sont des matériaux qui peuvent revenir à leur forme d'origine lorsqu'un stimulus approprié (par exemple de la chaleur) est prévu. Ces polymères sont programmés par cycle de mémoire de forme qui se compose de deux parties: une partie de la programmation qui donne un effet mémoire de forme (SME) à savoir la forme temporaire pour le polymère et la partie de récupération où il revient à sa forme initiale. Les SMP ont une faible rigidité, donc, produisent de grandes déformations récupérables, mais produisent des forces de récupération faibles. Cependant, les composites SMP produisent des forces de récupération plus grandes car ils sont relativement rigide mais ont des souches moins récupérables. En outre, de forts actionneurs à mémoire de forme peuvent être produits si deux effets différents peuvent être combinés dans une structure unique. Une structure déjà active (par exemple des alliages à mémoire de forme) peut être intégré dans SMP. Par conséquent, un fort actionneur couplé peut être obtenu. [...] / Shape memory polymers (SMPs) are the materials which can return to their original shape when a suitable stimulus (e.g. heat) is provided. These polymers are programmed through shape memory cycle that consists of two parts: programming part which gives shape memory effect (SME) i.e. temporary shape to the polymer and the recovery part which return it to its original shape. SMPs have low stiffness, therefore, produce large recoverable strains, but produce low recovery forces. However, SMP composites produce larger recovery forces as they are relatively rigid but have less recoverable strains. Moreover, strong shape memory actuators can be produced if two different effects can be combined in a single structure. An already active structure (e.g shape memory alloys) can be embedded in SMP. Consequently, a strong coupled actuator can be obtained. In this work, the shape memory property of CBCM composite (an active composite that works on bimetallic affect) has been studied. CBCM stands for controlled behavior of composite material. CBCM activeness and its SM property has been coupled together to obtain a strong actuator. SM property has been obtained through thermo-mechanical programming at a temperature higher than glass transition temperature (Tg) of Epoxy resin used for its fabrication. The CBCM actuating properties have been studied through different one-step recoveries (unconstrained, constrained and recovery under load). Moreover, different asymmetrical CBCM composites have been developed by changing the position and orientation of the different layers used. These have been studied for their different actuation properties. Similarly, multi-step recoveries (unconstrained and constrained) have also been performed to show multi step actuation capabilities in CBCM. The actuating properties of CBCM have also been compared with symmetrical composite (SYM) to show the advantage of coupled properties in CBCM. It has been found that CBCM has the ability to give high strain, high recovery forces. Also, it can recover under load and recover to its original position at the temperatures lower than the deforming temperature used in the programming cycle.